Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Contract negotiations between Mount Sinai and Anthem Blue Cross Blue Shield broke down this week, leaving the health system completely out of Anthem’s insurance network. The dispute reflects broader ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

CEO Kempton Presley provided an overview of its medication adherence technology and how it addresses challenges specific to dual-eligibles. Vice President, Product Management, Data and Ecosystem ...

Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business ...

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ...

Medicare is making two major changes to how it pays for cardiac care. Beginning this year, the Centers for Medicare & Medicaid Services (CMS) are moving away from paying solely for services performed ...

After Congress failed to pass a funding bill, the government shut down early Wednesday morning, which has significant implications for healthcare, including the future of telehealth flexibilities and ...